Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus

Responses of cytotoxic T-cells (Tc) to human cytomegalovirus (CMV) represent the predominant mechanism by which hosts resist CMV infection. The CMV major immediate-early protein (IE) is present throughout the virus replicative cycle. Studies were performed to determine whether Tc specific for IE effectively lyse CMV-infected targets and are thus capable of providing protective immunity against infection. After in vitro stimulation of peripheral blood mononuclear cells with CMV-infected autologous fibroblasts, Tc specific for IE were not readily detectable in CMV-reactive polyclonal Tc lines. However, after stimulation of peripheral blood mononuclear cells with cells selectively expressing IE, weak but detectable IE-specific Tc responses were observed. The frequency of IE-specific Tc clones derived from cultures stimulated with IE-expressing cells was 50 to 100 times lower than the frequency of Tc clones specific for other CMV proteins isolated from cultures stimulated with CMV-infected cells. All of the IE-specific Tc clones, which efficiently lysed targets selectively expressing IE, demonstrated minimal lysis of CMV-infected fibroblasts, despite abundant IE expression in these target cells. In contrast to these results with IE, other viral proteins were efficiently presented during all phases of CMV infection. These data suggest that CMV has evolved a unique mechanism for selectively limiting the presentation of the potentially immunogenic IE protein, which may preclude IE-specific Tc from providing protective immunity to CMV infection.

[1]  L. Gooding Virus proteins that counteract host immune defenses , 1992, Cell.

[2]  J. Grundy,et al.  Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus. , 1992, The Journal of general virology.

[3]  U. Koszinowski,et al.  Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment , 1992, The Journal of experimental medicine.

[4]  S. Riddell,et al.  Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. , 1992, Science.

[5]  E. Kieff,et al.  Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies , 1992, The Journal of experimental medicine.

[6]  F. Ennis,et al.  Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes , 1992, Journal of virology.

[7]  A. Campbell,et al.  An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T lymphocytes , 1992, Journal of virology.

[8]  S. Burrows,et al.  The specificity of recognition of a cytotoxic T lymphocyte epitope , 1992, European journal of immunology.

[9]  D. Nixon,et al.  Cytotoxic T-cell recognition of HIV proteins and peptides. , 1991, AIDS.

[10]  S. Riddell,et al.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.

[11]  W. Britt,et al.  Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. , 1991, Journal of immunology.

[12]  Claude M. Fauquet,et al.  The classification and nomenclature of viruses , 1976, Archives of Virology.

[13]  S. Riddell,et al.  The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. , 1990, Journal of immunological methods.

[14]  U. Koszinowski,et al.  Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase , 1989, Cell.

[15]  J. Nelson,et al.  Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region , 1989, Journal of virology.

[16]  J. Sissons,et al.  Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses , 1988, The Journal of experimental medicine.

[17]  S. Spector,et al.  Generation of human cytomegalovirus-specific cytotoxic T-lymphocytes in a short-term culture. , 1988, Journal of immunological methods.

[18]  S. Jonjić,et al.  A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection , 1988, Journal of virology.

[19]  J. Maryanski,et al.  "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Burgert,et al.  An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens , 1985, Cell.

[21]  G. Wilkinson,et al.  The structure of the major immediate early gene of human cytomegalovirus strain AD169. , 1985, Virus research.

[22]  R. Welsh,et al.  Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells , 1985, The Journal of experimental medicine.

[23]  A. Riggs,et al.  Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. R. Thomsen,et al.  Organization and expression of the immediate early genes of human cytomegalovirus , 1983, Journal of virology.

[25]  L. Borysiewicz,et al.  Human cytomegalovirus‐specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity , 1983, European journal of immunology.

[26]  W. Gibson Immediate-early proteins of human cytomegalovirus strains AD 169, Davis, and Towne differ in electrophoretic mobility. , 1981, Virology.

[27]  M. J. Tevethia,et al.  Immunoprecipitation of virus-specific immediate-early and early polypeptides from cells lytically infected with human cytomegalovirus strain AD 169. , 1981, Virology.

[28]  J. M. Cameron,et al.  Comparison of the immediate early polypeptides of human cytomegalovirus isolates. , 1981, The Journal of general virology.

[29]  D. R. Thomsen,et al.  Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection , 1981, Journal of virology.

[30]  C. Schmidt,et al.  Patterns of Transcription of Human Cytomegalovirus in Permissively Infected Cells , 1980, Journal of virology.

[31]  M. Kress,et al.  Human cytomegalovirus-induced immediate early antigens: analysis in sodium dodecyl sulfate-polyacrylamide gel electrophoresis after immunoprecipitation , 1979, Journal of virology.

[32]  C. Barnstable,et al.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. , 1979, Journal of immunology.

[33]  M. Stinski Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides , 1978, Journal of virology.